DNATRIX INC

Profile

Company Names

DNATRIX INC

Addresses

2450 HOLCOMBE BLVD., SUITE X+200, HOUSTON, TX 77021

ONE GREENWAY PLAZA, SUITE 930, HOUSTON, TX 77046

ONE GREENWAY PLAZA, SUITE 930, HOSTON, TX 77046

Phone Numbers

832.930.2401
713-715-6820

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,740,239.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-09-12 
$15,529,295.00 
$41,195,960.00 
$25,666,665.00 
Equity 
3
2014-10-06 
$12,781,419.00 
$18,800,000.00 
$6,018,581.00 
Equity 
2
2013-10-25 
$1,543,905.00 
$3,000,000.00 
$1,456,095.00 
Debt 
1
2012-07-20 
$885,620.00 
$885,620.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISAAC 
 
CHENG 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  BIOSCALE INC   |  EDISON PHARMACEUTICALS INC   |  ATREAON, INC.   |  SYNCHRONEURON INC.   |  AMYLYX PHARMACEUTICALS, INC.   |  TORPEDO DIAGNOSTICS, INC.   |  DNATRIX INC   |  ADJUVANCE TECHNOLOGIES INC.   |  INCARDA THERAPEUTICS, INC.   |  MEISSA VACCINES INC   |  TALLAC THERAPEUTICS, INC.   |  APNIMED, INC.   |  MEDRHYTHMS, INC.
IMRE 
 
KOVESDI 
EXECUTIVE OFFICER, DIRECTOR
DNATRIX INC
REENIE 
 
MCCARTHY 
DIRECTOR
FREIGHT FARMS, INC.   |  CO EVERYWHERE, INC.   |  DNATRIX INC
FRANCIS 
PATRICK 
MCCORMICK 
DIRECTOR
DNATRIX INC
BRIAN 
 
MOONEY 
EXECUTIVE OFFICER
DNATRIX INC   |  SPIRO MEDICAL INC.   |  MIRA ONCOLOGY, INC.
DREW 
 
PARDOLL 
DIRECTOR
ADURO BIOTECH   |  DNATRIX INC
FRANK 
 
TUFARO 
EXECUTIVE OFFICER, DIRECTOR
DNATRIX INC
DANIEL 
 
WATKINS 
EXECUTIVE OFFICER, DIRECTOR
VERTOS MEDICAL INC   |  ILLUMITEX, INC.   |  DNATRIX INC   |  RECOURSE BIOLOGICS, INC.
DANIEL 
M. 
WATKINS 
EXECUTIVE OFFICER, DIRECTOR
VERTOS MEDICAL INC   |  ILLUMITEX, INC.   |  CGATE HEALTH, INC.   |  DNATRIX INC   |  MERCURY FUND VENTURES III, L.P.   |  MERCURY FUND VENTURES IV, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-09-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-12 
2014-10-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-06 
2013-11-07
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Debt 
2013-10-25 
2012-08-03
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2012-07-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#